Rani Therapeutics Holdings, Inc. (RANI)
1.365
-0.02
(-1.80%)
USD |
NASDAQ |
Jan 20, 16:00
1.35
-0.02
(-1.10%)
After-Hours: 17:19
Rani Therapeutics Holdings Shareholders Equity (Quarterly): -7.86M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Exelixis, Inc. | 2.161B |
| Eli Lilly & Co. | 23.79B |
| Olema Pharmaceuticals, Inc. | 307.49M |
| CEL-SCI Corp. | 15.96M |
| AIM ImmunoTech, Inc. | -6.077M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.14M |
| Total Liabilities (Quarterly) | 22.11M |
| Debt to Equity Ratio | -2.233 |
| Current Ratio | 0.2588 |
| Net Debt Paydown Yield | 14.77% |